Adalimumab Biosimilar Yuflyma Gets Approval for Additional Pediatric Indications
The FDA has expanded the approval of Yuflyma (adalimumab-…
Man Utd Failed With £50 Million Mbeumo Alternative
Man United reportedly had a £50 million bid for Antoine Semenyo turned down by Bournemo…
Sweden Leads in Preparedness
Elisabeth Braw, a senior fellow at the Atlantic Council and author of "Goodbye Globalization", notes that inf…
Importance of Hiring a Fishers Personal Injury Lawyer
Accidents can happen in seconds, but their consequences can have a lasting impact on…
AI Offers New Pathways to Strengthen Site Leadership
Artificial intelligence can help identify key opinion leaders in emerging markets, im…
Global PAH Data Shows Rising Cases and Risk Factors in Elderly
Pulmonary arterial hypertension (PAH) has increased worldwide in older adul…
Deniliquin Bowlers Achieve Impressive Victories
The Deniliquin Bowling Club had a successful day on Saturday, with only one of the Weekend…
Syngene International Expands Capabilities
Syngene International, a global contract research, development and manufacturing organization (…
Spotting a Rare Lung Disease in Primary Care
Early recognition of rare diseases, such as autoimmune pulmonary alveolar proteinosis, is cru…
Global PAH Data Shows Rising Cases and Risk Factors in Elderly
Pulmonary arterial hypertension (PAH) has increased worldwide in older adul…